CRIS vs MET · rev $10.9M vs P/E 13, rev $77.08B
Curis Inc (CRIS) versus MetLife Inc (MET) — a side-by-side from cached financials, not a winner call.
Curis Inc (CRIS) is a biotechnology company listed on US.
MetLife Inc (MET) is a insurance - life company listed on US.
Latest reported CRIS revenue for 2024-12-31 was $10.9M. Net income was -$43.4M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CRIS currently screens at market cap $22.1M.
Latest reported MET revenue for 2025-12-31 was $77.08B. Net income was $3.38B. Revenue was up 8.6% from 2024-12-31 to 2025-12-31. MET currently screens at market cap $52.16B and trailing P/E 12.7.
CRIS currently screens at market cap $22.1M. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Not investment advice. Open the CRIS and MET stock pages for the full models.
Not investment advice.